FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

129482002: Galantamine hydrobromide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
208264019 Galantamine hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
733619018 Galantamine hydrobromide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
32241000188112 galantamine bromhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
814101000172115 bromhydrate de galantamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Galantamine hydrobromide Is a Product containing cholinesterase inhibitor false Inferred relationship Some
Galantamine hydrobromide Is a Central nervous system agent false Inferred relationship Some
Galantamine hydrobromide Is a Central nervous system agent (substance) true Inferred relationship Some
Galantamine hydrobromide Is a Substance with cholinesterase inhibitor mechanism of action false Inferred relationship Some
Galantamine hydrobromide Is a Galantamine (substance) false Inferred relationship Some
Galantamine hydrobromide This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Acetylcholine receptor agonist (disposition) false Inferred relationship Some
Galantamine hydrobromide This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Cholinesterase inhibitor false Inferred relationship Some
Galantamine hydrobromide This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Centrally acting acetylcholinesterase inhibitor (disposition) true Inferred relationship Some
Galantamine hydrobromide This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Galantamine (substance) true Inferred relationship Some
Galantamine hydrobromide Is a Centrally acting acetylcholinesterase inhibitor true Inferred relationship Some
Galantamine hydrobromide Is a Parasympathomimetic agent (substance) false Inferred relationship Some
Galantamine hydrobromide Is a Enzyme inhibitor false Inferred relationship Some
Galantamine hydrobromide Is a Benzazepine (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Galantamine hydrobromide 4mg/mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some
Galantamine 8mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some
Product containing precisely galantamine (as galantamine hydrobromide) 12 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some
Galantamine 16mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some
Galantamine (as galantamine hydrobromide) 8 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some
Galantamine 24mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some
Galantamine 4mg/mL s/f oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some 1
Galantamine (as galantamine hydrobromide) 8 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some 1
Product containing precisely galantamine (as galantamine hydrobromide) 12 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some 1
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 milliliter conventional release oral solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galantamine hydrobromide Inferred relationship Some
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Galantamine hydrobromide Inferred relationship Some 1
Product containing precisely galantamine (as galantamine hydrobromide) 12 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Galantamine hydrobromide Inferred relationship Some 1
Galantamine (as galantamine hydrobromide) 8 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Galantamine hydrobromide Inferred relationship Some 1
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Galantamine hydrobromide Inferred relationship Some 1
Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Galantamine hydrobromide Inferred relationship Some 1
Galantamine (as galantamine hydrobromide) 8 mg prolonged-release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Galantamine hydrobromide Inferred relationship Some 1
Product containing precisely galantamine (as galantamine hydrobromide) 24 milligram/1 each prolonged-release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Galantamine hydrobromide Inferred relationship Some 1

This concept is not in any reference sets

Back to Start